Venture Capital

New role for venture capital in pivotal trials

Interviewee/Contributer: Genghis Lloyd-Harris

Organisation: Abingworth LLP

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Sofinnova's Investment Strategy: Putting the entrepreneur first

Interviewee/Contributer: Antoine Papiernik

Organisation: Sofinnova Partners

Full text available to subscribers only. Click here for information on subscribing to MedNous.

A new venture capital model

Interviewee/Contributer: Kevin Johnson

Organisation: Index Ventures Management LLP

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Interview: 4-Antibody AG - How do you structure a biotech for divestment?

Interviewee/Contributer: Robert Burns

Organisation: 4-Antibody AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

The role of technology providers in biotech

Interviewee/Contributer: John Burt

Organisation: PolyTherics Ltd

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Investment pendulum swings back towards biotech

Interviewee/Contributer: Bart Bergstein

Organisation: Forbion Capital Partners

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Shire Plc adds new dimension to its strategy

Interviewee/Contributer: Gwen Melincoff

Organisation: Shire Plc

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Capital efficiency -- a new norm

Interviewee/Contributer: Werner Lanthaler

Organisation: Evotec AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Launch of Takeda Ventures

Interviewee/Contributer: Graeme Martin

Organisation: Takeda Ventures

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content